FDA HEAD ACKNOWLEDGES A PLAN FOR SAFETY SURVEILLANCE

FDA HEAD ACKNOWLEDGES A PLAN FOR SAFETY SURVEILLANCE Dr. Marion Gruber, Director, Office of Vaccines Research and Review,
Center for Biologics Evaluation and Research, FDA, discusses pharmacological vigilance systems not yet in place, which are essential to “really inform risk management.” DESCRIPTION:
Watch the full exposé here: http://bit.ly/HWEP145

Original source: https://www.youtube.com/watch?v=Er3aX__loWU

0 0 votes
Article Rating

Follow Highwire with Del Bigtree on:

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments